Hepatitis B Foundation hails decision by U.S. Public Health Service Corps to accept future applicants living with chronic hepatitis B infection and HIV <<Click here>>

Longtime Board Chair honored by his colleagues

Doylestown, Pa., July 14, 2022– The Hepatitis B Foundation's Board of Directors and leadership recognized Joel D. Rosen, Esq., at the board's recent meeting for his nearly two decades of service. A board member since 2003, he was chair of the board from 2009 until stepping down last month.

A conference room in the new building that houses the main offices of the Hepatitis B Foundation has been named in Mr. Rosen's honor.

Dr. Timothy M. Block, our founding President, now is Executive Chair of the board.

Block Rosenstanding Kassa3

Timothy M. Block, PhD, (left) Executive Chair of the Hepatitis B Foundation Board, Mr. Rosen (center) and Louis P. Kassa, III, MPA, President of the Pennsylvania Biotechnology Center (PABC) and Interim Chief Executive Officer of the PABC, Hepatitis B Foundation and Blumberg Institute.

The new building is on our Doylestown campus, which comprises four connected buildings on 10 acres. In addition to new labs, meeting rooms and a large event space, it provides offices for many scientists and the leadership of the Foundation, the Pennsylvania Biotechnology Center (PABC) and the Blumberg Institute. The PABC is an incubator that houses the Institute’s labs and nearly 50 small companies. 

Rosen with photo

Kassa Rosenseated Block3